Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders
暂无分享,去创建一个
J. Llop | P. Aguiar | L. Kingston | C. Elmore | U. Cossío | V. Gómez‐Vallejo | A. Vallejo-Illarramendi | Abraham Martín | J. Aizpurua | Maialen Sagartzazu-Aizpurua | G. Aldanondo | J. Bergare | M. Morcillo | Rossana Passannante | Pablo Marco-Moreno | P. Ferrón | Laura Vignau Arsuaga
[1] P. Gerk,et al. The Caco-2 Model: Modifications and Enhancements to Improve Efficiency and Predictive Performance. , 2022, International journal of pharmaceutics.
[2] Oluwole B. Akawa,et al. Simulation Models for Prediction of Bioavailability of Medicinal Drugs—the Interface Between Experiment and Computation , 2022, AAPS PharmSciTech.
[3] Chander S Digwal,et al. PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective , 2022, Frontiers in Medicine.
[4] H. Neumann,et al. Recent Developments for the Deuterium and Tritium Labeling of Organic Molecules. , 2022, Chemical reviews.
[5] Vishal B. Siramshetty,et al. Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability. , 2022, Bioorganic & medicinal chemistry.
[6] A. López de Munain,et al. Discovery of a novel family of FKBP12 "reshapers" and their use as calcium modulators in skeletal muscle under nitro-oxidative stress. , 2021, European journal of medicinal chemistry.
[7] Andreas Wree,et al. Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function. , 2019, Journal of visualized experiments : JoVE.
[8] F. Hausch,et al. FKBP Ligands—Where We Are and Where to Go? , 2018, Front. Pharmacol..
[9] K. Meilleur,et al. Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches , 2018, Neurotherapeutics.
[10] L. Nics,et al. An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N , 2018, The Journal of Nuclear Medicine.
[11] N. Srinivas,et al. Review of HPLC and LC-MS/MS assays for the determination of various nonsteroidal anti-androgens used in the treatment of prostate cancer. , 2018, Biomedical chromatography : BMC.
[12] M. Iino,et al. Genotype–Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel , 2016, Human mutation.
[13] J. Lanciego,et al. Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels , 2016, Journal of neurochemistry.
[14] Karen M. Alsante,et al. In silico prediction of pharmaceutical degradation pathways: a benchmarking study. , 2014, Molecular pharmaceutics.
[15] J. Llop,et al. Nitrogen-13: historical review and future perspectives. , 2014, Journal of labelled compounds & radiopharmaceuticals.
[16] Jordi Llop,et al. Assessing Lung Inflammation After Nanoparticle Inhalation Using 2-deoxy-2-[18F]fluoro-d-glucose Positron Emission Tomography Imaging , 2014, Molecular Imaging and Biology.
[17] J. Llop,et al. PET Imaging of Serotoninergic Neurotransmission with [11C]DASB and [18F]altanserin after Focal Cerebral Ischemia in Rats , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] Paolo Zanotti-Fregonara,et al. Kinetic analysis of [11C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A , 2013, EJNMMI Research.
[19] J. Llop,et al. On 11C Chemistry Reviews - Surveying and Filling the Gaps , 2013 .
[20] Chuang Lu,et al. Preclinical experimental models of drug metabolism and disposition in drug discovery and development , 2012 .
[21] J. Llop,et al. Facile and improved synthesis of [11C]Me‐QNB , 2012 .
[22] J. Llop,et al. Biodistribution and metabolism of 11C-labeled Kendine 91 in mice and rats. , 2012, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[23] J. Llop,et al. Fully automated and reproducible radiosynthesis of high specific activity [11C]raclopride and [11C]Pittsburgh compound-B using the combination of two commercial synthesizers , 2011, Nuclear medicine communications.
[24] T. Shiomi,et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. , 2011, Cell metabolism.
[25] Yong Zhang,et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..
[26] S. Matecki,et al. Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle , 2009, Nature Medicine.
[27] L. Bass,et al. A method to estimate dispersion in sampling catheters and to calculate dispersion-free blood time-activity curves. , 2008, Medical physics.
[28] L. Jia,et al. The conduct of drug metabolism studies considered good practice (II): in vitro experiments. , 2007, Current drug metabolism.
[29] Corey W. Liu,et al. Characterization of the FKBP.rapamycin.FRB ternary complex. , 2005, Journal of the American Chemical Society.
[30] A. Stammati,et al. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics , 2005, Cell Biology and Toxicology.
[31] H. van de Waterbeemd,et al. ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.
[32] I. Pastan,et al. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Kessler,et al. Analysis of emission tomographic scan data: limitations imposed by resolution and background. , 1984, Journal of computer assisted tomography.
[34] E. Hoffman,et al. Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.